1. Responsible for the construction and optimization of animal disease model;2. Be responsible for designing reasonable animal experiment scheme, scheme optimization and method development, selecting appropriate animal model, leading project team personnel to conduct pharmacodynamic research, contro
Learn MoreNEWS
-
Cascade recently announced tha···
2023 03-15 -
On February 8, 2022, Science p···
2023 01-12 -
Recently, Cascade announced th···
2023 01-12 -
Recently, Cascade announced th···
2023 01-12 -
On December 7, 2021, Cascade P···
2023 01-12 -
With the increasing prevalence···
2021 11-03 -
On October 23, 2021, Dr. Eric ···
2021 10-23 -
Recently, Cascade Pharmaceutic···
2021 10-20 -
PBC is a disease caused by aut···
2021 06-12 -
At 3 p.m. on September 16, 202···
2021 03-09
-
Cascade recently announced thatthe new FXR agonist CS0159, jointly developed by the team of Eric Xu, founder of Shanghai Institute of Medicine, and Li Jia, team of Shanghai Institute of Medicine, is aimed at NASH-CS0159-002 carried out in the United States for non-alcoholic fatty liver disease
-
On February 8, 2022, Science published online the latest results of "Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody" jointly researched by Eric Xu and Yin Wanchao of the Shanghai Institute of Pharmaceutical Research
